市场调查报告书
商品编码
1466235
人工呼吸器市场:按移动性、模式、类型、介面和最终用户划分 - 2024-2030 年全球预测Ventilators Market by Mobility (Intensive Care Ventilator, Portable Ventilator), Mode (Dual or Combined Mode Ventilation, Pressure Mode Ventilation, Volume Mode Ventilation), Type, Interface, End User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年人工呼吸器市场规模为36.3亿美元,2024年达38.5亿美元,预计2030年将达55.4亿美元,复合年增长率为6.22%。
人工呼吸器是医疗设备。它在重症患者,包括患有严重肺部疾病、神经系统疾病和创伤相关损伤的患者。新型冠状病毒主要针对呼吸系统,引起类似肺炎的症状,并可能进展为需要机械通气才能生存的急性呼吸衰竭。呼吸系统疾病和术后护理的增加增加了对人工呼吸器,特别是在居家照护环境中。我们也努力向医院和防区部署人工呼吸器,以支援充分的医疗保健。然而,人工呼吸器的技术限制阻碍了它们对特定疾病状态的适用性。业界也发生了产品召回事件,凸显了严格品管措施的必要性。具有先进功能的人工呼吸器的引入有望改善患者的治疗效果并提高效率。政府对医用人工呼吸器的核准为行业创新和成长创造了有利的环境。
主要市场统计 | |
---|---|
基准年[2023] | 36.3亿美元 |
预测年份 [2024] | 38.5亿美元 |
预测年份 [2030] | 55.4亿美元 |
复合年增长率(%) | 6.22% |
流动性高阶加护治疗在重症加护环境中需要人工呼吸器
加护治疗人工呼吸器是高性能重症患者监护设备,旨在为患有呼吸衰竭或其他需要机械通气的严重医疗状况的患者提供支援。该设备主要用于医院和医疗机构的加护病房(ICU)、急诊室以及手术室。可携式人工呼吸器是一种紧凑、轻巧的设备,旨在为传统医院环境以外的地方的患者提供呼吸辅助,例如家庭护理、救护车、长期护理设施和设施间运输。可携式人工呼吸器的通用功能包括电池操作选项、安全警报、即时监控和用户友好的介面。
模式:双模式或组合模式通气偏好,以提供最佳的呼吸支持
双模式通气或组合模式通气是基于压力和容量的策略的结合,可为患者提供最佳的呼吸支持。它旨在确保足够的肺復张并防止过度充气,同时允许临床医生同时控制潮气量和吸气压。这种模式最大限度地提高了患者的舒适度以及与人工呼吸器的可调性,减少了人工呼吸器引起的肺损伤 (VILI) 等併发症的可能性。压力模式通气是急性呼吸窘迫症候群(ARDS) 和其他需要气道压力控制的疾病患者的合适选择。在此方法中,人工呼吸器以指定压力水平输送呼吸,同时监测患者的吸气强度。压力模式通气的主要优点是它紧密模仿自然呼吸模式,改善患者和人工呼吸器的同步性。对于机械通气期间需要恆定潮气量的患者来说,容量模式通气仍然是首选。在该技术中,无论气道压力或肺顺应性如何变化,人工呼吸器都会保持预设的潮气量。它对于患有限制性肺病的患者特别有用,可以防止通气不足并确保足够的气体交换。
新生儿人工呼吸器操作的改进可提供温和的支持,防止因肺部发育不成熟和气道脆弱而引起的併发症。
成人和儿童用人工呼吸器旨在为呼吸衰竭或功能不全的患者(通常为 1 岁以上)提供机械通气。这些设备专为满足该年龄层的独特生理需求而量身定制,确保提供足够的通气支持,同时最大限度地降低挤压伤等併发症的风险。新生儿或新生儿人工呼吸器可满足新生儿(4 週以下)和婴儿(1 岁以下)独特的呼吸支援需求。早产儿常呼吸系统发育不全,导致早产儿呼吸暂停症候群、呼吸窘迫症候群、支气管肺发育不良等病理状况。新生儿人工呼吸器旨在提供温和的通气,同时最大限度地减少由于这些患者体质娇弱而导致的氧中毒併发症。
由于界面併发症和低风险而采用非侵入性通气
侵入性通气涉及将气管插管插入病人气管,直接向肺部提供机械通气。当患者严重或非侵入性呼吸支持方法不足或不足时,可使用此方法。非侵入性通气 (NIV) 无需使用气管插管即可提供呼吸支持。当患者病情严重且有创通气併发症的併发症超过潜在益处时,可使用 NIV。这种方法通常用于慢性阻塞性肺病(COPD)恶化、急性呼吸衰竭以及某些睡眠障碍(例如阻塞型睡眠呼吸中止症)的情况。
最终用户:医院对具有许多先进功能的多功能人工呼吸器的需求
门诊手术中心 (ASC) 是一家进行不需要住院的门诊手术的医疗机构。 ASC 中对人工呼吸器的需求对于在各种外科手术期间提供呼吸支持至关重要。在居家医疗中,它主要用于在医院外需要长期或慢性通气支持的患者。在家庭护理环境中,需要具有更高可用性、低噪音水平、紧凑性和远端监控功能的人工呼吸器,以最大限度地减少看护者的负担,同时确保患者的安全和舒适。在医院,重症监护病房 (ICU)、新生儿加护病房(NICU)、急诊室 (ED) 以及心胸外科等专业外科手术的需求量很大,这些是呼吸器的主要使用案例。在这些环境中,人工呼吸器必须可靠、多功能,并提供广泛的高级功能,例如保护性通气策略、疏散通讯协定和自动决策支援。
区域洞察
在美洲,尤其是北美,人工呼吸器市场在疫情高峰期出现成长,并且由于术后护理的增加,需求持续增加。区域企业扩大了产能,并引进了先进的人工呼吸器,以满足不断增长的设备需求。在亚洲,人工呼吸器的需求在 2020 年初激增,催生了新的进入者。该地区拥有多元化的医疗基础设施,创造了多元化的市场。中国和日本等国家是成熟的医疗设备製造商,而其他国家则发展迅速。亚洲企业抓住了这一机会,扩大製造能力以满足国内需求并向世界各地出口。在欧洲,义大利、西班牙和英国正致力于改善医疗基础设施,频繁升级包括人工呼吸器在内的医疗设备。该地区的医疗保健市场成熟,有关人工呼吸器品质的法规也很严格。该地区的市场开拓公司正在政府资助下致力于开发先进的人工呼吸器技术。
FPNV定位矩阵
FPNV定位矩阵对于评估人工呼吸器市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对人工呼吸器市场供应商的现状进行富有洞察力和深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.人工呼吸器市场的市场规模和预测是多少?
2.人工呼吸器市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些?
3.人工呼吸器市场的技术趋势和法规结构是什么?
4.人工呼吸器市场主要厂商的市场占有率是多少?
5.进入人工呼吸器市场合适的型态和策略手段是什么?
[196 Pages Report] The Ventilators Market size was estimated at USD 3.63 billion in 2023 and expected to reach USD 3.85 billion in 2024, at a CAGR 6.22% to reach USD 5.54 billion by 2030.
A ventilator is a medical device that provides artificial respiration or assisted breathing to patients experiencing respiratory failure. It plays an essential role in managing severely ill patients, including those suffering from severe lung diseases, neurological conditions, and trauma-related injuries. The novel coronavirus primarily targets the respiratory system, leading to pneumonia-like symptoms that can progress into acute respiratory failure requiring mechanical ventilation for survival. The increasing incidence of respiratory diseases and post-surgical care has led to a rise in the requirement for ventilators, particularly in home care settings. There are initiatives to deploy ventilators in hospitals and defense areas to ensure adequate healthcare support. However, technical limitations of ventilators have hindered their compatibility with certain disease states. The industry has witnessed some product recalls, which focus on the need for strict quality control measures. The introduction of intelligent ventilators with advanced features is expected to improve patient outcomes and increase efficiency. Favorable government approvals for medical ventilators provide an encouraging environment for innovation and growth in the industry.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 3.63 billion |
Estimated Year [2024] | USD 3.85 billion |
Forecast Year [2030] | USD 5.54 billion |
CAGR (%) | 6.22% |
Mobility: Need for advanced intensive care ventilators for critical care settings
An intensive care ventilator is a high-performance, critical care device designed to support patients with respiratory failure or other severe medical conditions requiring mechanical ventilation. These devices are primarily used in intensive care units (ICUs), emergency departments, and operating rooms in hospitals and healthcare facilities. Portable ventilators are compact and lightweight devices designed for providing respiratory support to patients outside traditional hospital settings such as homecare settings, ambulances, long-term care facilities, or during interfacility transport. Some common features in portable ventilators include battery operation options, alarms for safety purposes, real-time monitoring, and user-friendly interfaces.
Mode: Preference for dual or combined mode ventilation to provide optimal respiratory support
Dual or combined mode ventilation is a fusion of pressure and volume-based strategies to provide optimal respiratory support to patients. It is designed to ensure adequate lung recruitment and prevent over-distension while allowing clinicians to control tidal volume and inspiratory pressure simultaneously. This mode maximizes patient comfort and synchrony with the ventilator, leading to reduced chances of complications such as ventilator-induced lung injury (VILI). Pressure mode ventilation is a suitable choice for patients with acute respiratory distress syndrome (ARDS) and other conditions requiring controlled airway pressures. In this method, the ventilator delivers breaths at a predetermined pressure level while monitoring the patient's inspiratory effort. The primary advantage of pressure mode ventilation is that it closely mimics natural breathing patterns, providing better patient-ventilator synchrony. Volume mode ventilation remains a preferred option for patients who require consistent tidal volumes during mechanical ventilation. Under this technique, the ventilator maintains a pre-set tidal volume regardless of changes in airway pressure or lung compliance. It is particularly useful in preventing hypoventilation and ensuring adequate gas exchange in patients with restrictive lung diseases.
Type: Improvements in operations of neonatal ventilators to enable gentle support that safeguards against complications from immature lungs and fragile airways
Adult and pediatric ventilators are designed to provide mechanical ventilation for patients with respiratory failure or insufficiency, typically aged one year and above. These devices are tailored to meet the unique physiological needs of this age group, ensuring adequate ventilation support while minimizing the risk of complications such as barotrauma. Infant or neonatal ventilators cater to the specific respiratory support needs of newborns (up to four weeks old) and infants (up to one-year-old). Premature babies often have underdeveloped respiratory systems, resulting in conditions such as apnea of prematurity, respiratory distress syndrome, and bronchopulmonary dysplasia. Neonatal ventilators are designed to provide gentle ventilation while minimizing complications of oxygen toxicity due to the delicate nature of these patients.
Interface: Adoption of non-invasive ventilation owing to their low complication and risks
Invasive ventilation involves placing an endotracheal (ET) tube into the trachea of the patient to deliver mechanical ventilation directly to the lungs. This method is preferred when a patient's condition is critical or when non-invasive methods are insufficient or unsuitable for adequate respiratory support. Non-invasive ventilation (NIV) delivers respiratory support without an endotracheal tube. NIV is used when the patient's condition is less severe and the risk of complications from invasive ventilation is greater than the potential benefits. This method is often employed in cases such as chronic obstructive pulmonary disease (COPD) exacerbations, acute respiratory failure, and certain sleep disorders such as obstructive sleep apnea.
End User: Requirement for highly versatile ventilators with numerous advanced features in hospitals
Ambulatory surgical centers (ASCs) are healthcare facilities that perform outpatient surgeries that do not require hospitalization. The need for ventilators in ASCs is essential, as these devices provide respiratory support during various surgical procedures. The home care setting primarily serves patients requiring long-term or chronic ventilation support outside the hospital environment. Users prefer ventilators with improved user-friendliness, low noise levels, compactness, and remote monitoring features to ensure patient safety and comfort while minimizing caregiver burden in homecare settings. Hospitals represent a major use case for ventilators due to the high need for critical care units (ICUs), neonatal intensive care units (NICUs), emergency departments (EDs), and more specialized surgical applications such as cardiothoracic surgery. In this setting, ventilators must be reliable and versatile and offer a wide range of advanced features such as lung-protective ventilation strategies, weaning protocols, and automated decision support.
Regional Insights
In the Americas, specifically in North America, the market for ventilators grew during the pandemic's peak and has continued to observe requirements owing to the rising cases of post-surgery care. Regional players expanded their production capacities and introduced advanced intelligent ventilators to meet the rising equipment requirements. Asia witnessed an abrupt increase in the need for ventilators during early 2020, which encouraged new regional companies to enter the market. The region portrays a diverse market with variations in healthcare infrastructure. Countries such as China and Japan have well-established medical equipment manufacturing companies, while others are developing rapidly. Asian firms seized this opportunity by expanding their manufacturing capabilities to cater to domestic needs and to export ventilators worldwide. In Europe, Italy, Spain, and the United Kingdom, with an emphasis on advancing healthcare infrastructure with frequent medical equipment upgrades, including ventilators. The region has a mature healthcare market with strong regulations on ventilator quality. Market players in the region are working on developing advanced ventilator technologies supported by government funding.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Ventilators Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Ventilators Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Ventilators Market, highlighting leading vendors and their innovative profiles. These include Abhay Raj International, Acoma Medical Industry Co Ltd., AgVa Healthcare, Air Liquide S.A., ARI Medical Technology Co., Ltd., Avante Health Solutions, aXcent medical GmbH, Baxter International Inc., Beijing Aeonmed Co., Ltd., Bio-Med Devices, Inc., Biosys Biyomedikal Muhendislik A.S., Bunnell Incorporated, CorVent Medical Inc., Dima Italia, Dragerwerk AG & Co. KGaA, eVent Medical, Fisher & Paykel Healthcare Limited, Flexicare Medical Limited, Flight-Medical Innovations Ltd., GE HealthCare Technologies, Inc., Getinge AB, Hamilton Medical AG, Hayek Medical by United Hayek Company, Healicom Medical Equipment Co., Ltd., Koninklijke Philips N.V., Leistung Brasil, Lowenstein Medical Innovation GmbH & Co. KG, Medtronic PLC, Nanjing Superstar Medical Equipment Co.,Ltd., Narang Medical Limited, Nihon Kohden Corporation, O-Two Medical Technologies Inc., Resmed, Inc., Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Siemens AG, Smith Group PLC, SMTC Corporation, Sysadvance-Sistemas de Engenharia, SA, Ventec Life Systems, Inc., Vexos Corporation, Vyaire Medical, Inc., WEINMANN Emergency Medical Technology GmbH + Co. KG, and Zoll Medical Corporation.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Ventilators Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Ventilators Market?
3. What are the technology trends and regulatory frameworks in the Ventilators Market?
4. What is the market share of the leading vendors in the Ventilators Market?
5. Which modes and strategic moves are suitable for entering the Ventilators Market?